Corrigendum: Different Patient Subgroup Different Maintenance, Proteasome Inhibitors or Immunomodulators Maintenance for Newly Diagnosed Multiple Myeloma: A 7-Year Single-Center Data in China

Front Oncol. 2021 Sep 2:11:740715. doi: 10.3389/fonc.2021.740715. eCollection 2021.

Authors

Xiaoyan Han¹, Chunxiang Jin¹, Gaofeng Zheng¹, Donghua He¹, Yi Zhao¹, Yi Li¹, Wenjun Wu¹, Weiyan Zheng¹, Guoqing Wei¹, Enfan Zhang¹, He Huang¹, Jingsong He¹, Zhen Cai^{1

2}

Affiliations

¹ Bone Marrow Transplantation Center, Department of Hematology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
² Institute of Hematology, Zhejiang University, Hangzhou, China.

Abstract

[This corrects the article DOI: 10.3389/fonc.2021.665217.].

Keywords: immunomodulators; maintenance; multiple myeloma; optimal maintenance duration; proteasome inhibitors.

Copyright © 2021 Han, Jin, Zheng, He, Zhao, Li, Wu, Zheng, Wei, Zhang, Huang, He and Cai.

Publication types

Published Erratum